openPR Logo
Press release

Recombinant Protein Market - Global Industry insights 2025

07-05-2018 03:47 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Recombinant Protein Market - Global Industry insights 2025

Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used extensively by researchers to research cancer signaling pathways and functioning. Recombinant immune checkpoint such as PD-1/PD-L1 Inhibitor 1 and PD-1/PD-L1 Inhibitor 2, which directly targets programmed death-1 (PD-1) and programmed death ligand-1 and 2 (PD-L1) are used for research purposes. Moreover, proteins such as CD226, CD40 Ligand/TRAP, and Human CellExp CTLA4/CD152 are extensively used in cancer therapies research.

To get holistic SAMPLE of the report including table of contents: https://www.coherentmarketinsights.com/insight/request-sample/1516

Market Dynamics

Increasing demand for recombinant proteins for basic research has supported growth of recombinant protein market. Manufacturers are involved in recombinant protein product innovation in order to improve research outcomes along with improvements in other areas such as expression techniques, and protein purification techniques, which compliments growth of the recombinant protein market. The market is expected to gain significant growth, owing increasing adoption of biologics and biosimilars, which will in turn impact recombinant proteins market, along with rising prevalence of chronic diseases such as cancer. Furthermore, availability of wide number of innovative recombinant proteins from various sources such as human and animal, lack of suitable alternative for basic protein related therapies research, and increasing demand for biological products is expected to fuel growth of the market

Key features of the study:

This report provides in-depth analysis of recombinant protein market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global recombinant protein market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Crown Bioscience, Inc., ProSpec Tany TechnoGene, Ltd., BPS Bioscience, Inc., Sigma Aldrich Company Ltd., Novoprotein Scientific, PeproTech, Inc., Feldan Bio, Inc., BioVision, Inc., HumanZyme, Inc., and GenScript Biotech Corporation

Browse Research Report At: https://www.coherentmarketinsights.com/market-insight/recombinant-protein-market-1516

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the recombinant protein market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: https://globalresearchtrends.blogspot.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant Protein Market - Global Industry insights 2025 here

News-ID: 1112220 • Views:

More Releases from Coherent Market Insights

U.S. Clinical Laboratory Services Market Exclusive Report with Detailed Study Analysis By 2025-2032 | Siemens Healthineers • Roche Diagnostics • Abbott Laboratories
U.S. Clinical Laboratory Services Market Exclusive Report with Detailed Study An …
Coherent Market Insights has released a report titled "U.S. Clinical Laboratory Services Market 2025-2032: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins. ➤
Orthopedic Regenerative Medicine with Detailed Study Analysis 2025-2032 | Anika Therapeutics, Inc and Arthrex
Orthopedic Regenerative Medicine with Detailed Study Analysis 2025-2032 | Anika …
The Orthopedic Regenerative Medicine market is estimated to be valued at USD 11.68 Bn in 2025 and is expected to reach USD 23.79 Bn by 2032, growing at a compound annual growth rate CAGR of 10.7% from 2025 to 2032. ➤ The latest Qualitative Research Report on the Orthopedic Regenerative Medicine Market 2025, published by Coherent Market Insights, delivers in-depth insights into both global and regional markets, which are anticipated to
Asia Pacific Wound Care Biologics Market Growth in Future Scope 2025-2032 | Smith & Nephew Plc • Organogenesis Inc. • Integra LifeSciences Holdings Corporation
Asia Pacific Wound Care Biologics Market Growth in Future Scope 2025-2032 | Smit …
The Asia Pacific Wound Care Biologics market is estimated to be valued at USD 296.1 Mn in 2025 and is expected to reach USD 533.8 Mn by 2032, growing at a compound annual growth rate CAGR of 7.6% from 2025 to 2032. ➤ The qualitative latest Research report (2025-2032) on the Asia Pacific Wound Care Biologics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges,
Future Scope of Premium Potting Soils Market Set for Significant Growth by 2025 - Comprehensive Competitive Landscape Through 2032
Future Scope of Premium Potting Soils Market Set for Significant Growth by 2025 …
The Premium Potting Soils market is estimated to be valued at USD 1,598.4 Mn in 2025 and is expected to reach USD 1,855.1 Mn by 2032, growing at a compound annual growth rate CAGR of 3.5% from 2025 to 2032. ➤ The Latest Report, titled Premium Potting Soils Market includes a detailed analysis of current market conditions, market players, regions, types, applications, Opportunity and Forecast 2025-2032. The report provides a detailed

All 5 Releases


More Releases for Recombinant

Recombinant Human Endostatin Market Experiences Surge Due to Innovations in Reco …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Human Endostatin Market - (By Type (purity 95% and others) And By Application (medical care, scientific research and others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Recombinant Human Endostatin Market is valued at US$ 133.3 Mn in 2023, and it is expected to
Recombinant Chemicals Market Expands with Growing Adoption of Recombinant DNA an …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Chemicals Market - (By Product Type (Recombinant Proteins, Recombinant DNAs, Recombinant Peptides, Others), By Technology (Microbial Expression Systems, Mammalian Cell Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Cell-free Expression Systems), By Application (Drug Development, Vaccine Production, Therapeutics, Cell Line Development, Agriculture, Food and Beverage, Others)), Trends, Industry Competition Analysis, Revenue and Forecast
Recombinant Collagen Market Size and Forecast
Recombinant Collagen Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030. Recombinant Collagen Market Outlook and Investment Analysis Top companies Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech, Jiangsu Trautec Medical Technology, OriGene Technologies Recombinant Collagen Market: Trends & Investment Analysis Market Growth: The recombinant collagen
Global Recombinant Cell Culture Supplements Market Size - By Product Type(Recomb …
Recombinant Cell Culture Supplements Market Insights: Trends, Drivers, and Outlook 2024 - 2031 Recombinant Cell Culture Supplements Market Scope: Unveiling Today's Trends Recombinant Cell Culture Supplements are specialized products designed to enhance growth and productivity in cells used for research and bioproduction. The market for these supplements is experiencing substantial growth, driven by the rising demand for biopharmaceuticals and advancements in biotechnology. Increasing investments in research and development activities also contribute to market
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022. The next